Partner Content Partner Content Ophthalmic Drug Delivery Development - Trials and Tribulatio... Ophthalmic Drug Delivery Development Workshop
Partner Content Partner Content Interactive Pre-conference Workshop announced for Injectable... Workshop on Developing apps for Connected Drug Delivery
Partner Content Partner Content Duke University Medical Centre to lead a workshop at Biobank... Duke University Medical Centre to lead a workshop
Partner Content Partner Content BioPharmaLogic, Antikor Biopharma and UCL Host Two Workshops... SMi's 6th annual ADC Conference
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
